Different genetic mutation status also impacts CRC survival, where the CRC patients with a positive mutation of LRP1B have a higher recurrence rate and shorter progression-free survival (PFS) compared to those with a positive mutation of FAT4. 7Therefore, CRC genetic testing is critical in improving predictions of CRC prognostics and survival rate. Here, LRP1B is linked to colorectal carcinoma.